COVID-19 has left healthcare systems seeking home care options for chronic respiratory and other patients requiring regular pulmonary function testing, keeping patients safe at home and reducing the burden on the already overwhelmed hospitals around the world.
The critical need for home spirometry
- COVID-19 causes short- or long-term respiratory distress (1) or lung damage (2) in severely affected individuals.
- Patients with chronic respiratory illnesses (e.g. asthma, chronic obstructive pulmonary disease, Cystic Fibrosis, Lung transplant recipients) are considered as a high-risk group for COVID-19-related complications
- People need to self-isolate or stay at home to minimize spread (‘flatten the curve’)
- People need to self-isolate or stay at home to protect patients and personnel in hospitals (3)
- People need to self-isolate or stay at home to help reduce the current burden on healthcare systems For all of these reasons,
The role of Spirohome Personal
- It addresses the current need of millions of chronic respiratory disease patients who require or will benefit from remote monitoring/telehealth services in lung health tracking
- It keeps ‘at-risk’ groups safe at home, reducing their risk of exposure to COVID-19
- It minimises contact between healthcare personnel and hospitalised patients and potential COVID-19 carriers who could/should conduct spirometry at home
- It frees current health system resources that are already overwhelmed by the current COVID-19 pandemic
- It alerts the patient about any declines in lung health, allowing quick intervention against symptom onset and prevents unnecessary hospitalisations
- It is a tool for continued monitoring of the thousands of recovering COVID-19 patients left with compromised respiratory capacity - report from China indicates
- It will collect data regarding COVID-19 impacts on lung function to be put towards COVID-19 research and treatment
- It is, for both patients and healthcare systems, a cheaper way for continuous monitoring of respiratory disease patients
- TamIt advocates self-management of respiratory disease to increase awareness and knowledge amongst patients or carers
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.
- Coronavirus & Asthma: How to Cut Risks and Keep Control